Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States
Currently in the United States, Human Papillomavirus (HPV) vaccination coverage among eligible individuals is lower compared to coverage goals of 80% set by the HealthyPeople 2030 initiative. In this study, we used the National Health and Nutrition Examination Survey (NHANES) 2015–2016 and 2017–2018...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2021.1989919 |
| _version_ | 1797673241805848576 |
|---|---|
| author | Kunal Goel Lavanya Vasudevan |
| author_facet | Kunal Goel Lavanya Vasudevan |
| author_sort | Kunal Goel |
| collection | DOAJ |
| description | Currently in the United States, Human Papillomavirus (HPV) vaccination coverage among eligible individuals is lower compared to coverage goals of 80% set by the HealthyPeople 2030 initiative. In this study, we used the National Health and Nutrition Examination Survey (NHANES) 2015–2016 and 2017–2018 datasets to determine the association between HPV vaccine initiation among individuals of ages 9 to 26 years and their patterns of healthcare access and utilization. In particular, we examined the following healthcare characteristics: 1) having a routine place of healthcare, 2) having health insurance coverage, 3) frequency of healthcare visits per year, and 4) type of routine place of healthcare (outpatient primary care vs. ED, etc.). We fit independent multivariable logistic regression models for each NHANES dataset and controlled for sociodemographic characteristics and interactions with healthcare access and utilization characteristics. Our findings suggest that HPV vaccine initiation is positively associated with having a routine place of healthcare (2015–2016: aOR 1.92, 95% CI 1.25–2.95; 2017–2018: aOR 1.99, 95% CI 1.07–3.68). Relatedly, HPV vaccine initiation is negatively associated with never having received healthcare in the past year (2015–2016: aOR 0.61, 95% CI 0.41–0.90; 2017–2018: aOR 0.45, 95% CI 0.27–0.75). The results of this study suggest that interventions to promote HPV vaccination should include strategies that promote access to and utilization of routine health care services. Our findings are particularly salient in light of the drop in HPV vaccine initiation and healthcare access and utilization among adolescents during the COVID-19 pandemic. |
| first_indexed | 2024-03-11T21:42:42Z |
| format | Article |
| id | doaj.art-5ebac03712aa486e978f6e8f0b630c48 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:42:42Z |
| publishDate | 2021-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-5ebac03712aa486e978f6e8f0b630c482023-09-26T12:51:26ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2021-12-0117125390539610.1080/21645515.2021.19899191989919Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United StatesKunal Goel0Lavanya Vasudevan1Duke University School of MedicineDuke UniversityCurrently in the United States, Human Papillomavirus (HPV) vaccination coverage among eligible individuals is lower compared to coverage goals of 80% set by the HealthyPeople 2030 initiative. In this study, we used the National Health and Nutrition Examination Survey (NHANES) 2015–2016 and 2017–2018 datasets to determine the association between HPV vaccine initiation among individuals of ages 9 to 26 years and their patterns of healthcare access and utilization. In particular, we examined the following healthcare characteristics: 1) having a routine place of healthcare, 2) having health insurance coverage, 3) frequency of healthcare visits per year, and 4) type of routine place of healthcare (outpatient primary care vs. ED, etc.). We fit independent multivariable logistic regression models for each NHANES dataset and controlled for sociodemographic characteristics and interactions with healthcare access and utilization characteristics. Our findings suggest that HPV vaccine initiation is positively associated with having a routine place of healthcare (2015–2016: aOR 1.92, 95% CI 1.25–2.95; 2017–2018: aOR 1.99, 95% CI 1.07–3.68). Relatedly, HPV vaccine initiation is negatively associated with never having received healthcare in the past year (2015–2016: aOR 0.61, 95% CI 0.41–0.90; 2017–2018: aOR 0.45, 95% CI 0.27–0.75). The results of this study suggest that interventions to promote HPV vaccination should include strategies that promote access to and utilization of routine health care services. Our findings are particularly salient in light of the drop in HPV vaccine initiation and healthcare access and utilization among adolescents during the COVID-19 pandemic.http://dx.doi.org/10.1080/21645515.2021.1989919hpv vaccinevaccination uptakehuman papilloma virus (hpv)cervical canceroncogenic virushealthcare accesshealth insuranceadolescentcovid-19united states |
| spellingShingle | Kunal Goel Lavanya Vasudevan Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States Human Vaccines & Immunotherapeutics hpv vaccine vaccination uptake human papilloma virus (hpv) cervical cancer oncogenic virus healthcare access health insurance adolescent covid-19 united states |
| title | Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States |
| title_full | Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States |
| title_fullStr | Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States |
| title_full_unstemmed | Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States |
| title_short | Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States |
| title_sort | disparities in healthcare access and utilization and human papillomavirus hpv vaccine initiation in the united states |
| topic | hpv vaccine vaccination uptake human papilloma virus (hpv) cervical cancer oncogenic virus healthcare access health insurance adolescent covid-19 united states |
| url | http://dx.doi.org/10.1080/21645515.2021.1989919 |
| work_keys_str_mv | AT kunalgoel disparitiesinhealthcareaccessandutilizationandhumanpapillomavirushpvvaccineinitiationintheunitedstates AT lavanyavasudevan disparitiesinhealthcareaccessandutilizationandhumanpapillomavirushpvvaccineinitiationintheunitedstates |